Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laser Therapy | 9 | 2023 | 411 | 3.420 |
Why?
|
Drug Resistant Epilepsy | 8 | 2023 | 181 | 3.050 |
Why?
|
Epilepsy | 18 | 2024 | 883 | 2.770 |
Why?
|
Hypothalamic Diseases | 6 | 2022 | 66 | 2.760 |
Why?
|
Hamartoma | 6 | 2022 | 115 | 2.700 |
Why?
|
Magnetic Resonance Imaging | 25 | 2023 | 7702 | 1.590 |
Why?
|
Rhizotomy | 2 | 2021 | 13 | 1.510 |
Why?
|
Hemispherectomy | 3 | 2023 | 25 | 1.450 |
Why?
|
Cerebral Palsy | 2 | 2021 | 63 | 1.400 |
Why?
|
Seizures | 8 | 2023 | 989 | 1.270 |
Why?
|
Electrocorticography | 4 | 2024 | 72 | 1.200 |
Why?
|
Neural Pathways | 2 | 2019 | 298 | 1.130 |
Why?
|
Dystonia | 2 | 2019 | 163 | 1.050 |
Why?
|
Epilepsies, Partial | 5 | 2020 | 111 | 1.000 |
Why?
|
Muscle Spasticity | 2 | 2021 | 74 | 0.890 |
Why?
|
Neurosurgical Procedures | 8 | 2022 | 609 | 0.840 |
Why?
|
Stereotaxic Techniques | 4 | 2021 | 172 | 0.810 |
Why?
|
Rest | 2 | 2019 | 71 | 0.780 |
Why?
|
Spinal Fusion | 10 | 2012 | 149 | 0.700 |
Why?
|
Hypothalamic Neoplasms | 1 | 2018 | 21 | 0.670 |
Why?
|
Child | 48 | 2023 | 29154 | 0.670 |
Why?
|
Electroencephalography | 9 | 2024 | 898 | 0.670 |
Why?
|
Child, Preschool | 32 | 2023 | 16273 | 0.650 |
Why?
|
Brain | 7 | 2024 | 4113 | 0.620 |
Why?
|
Tuberous Sclerosis | 4 | 2023 | 136 | 0.610 |
Why?
|
Poloxamer | 3 | 2007 | 15 | 0.580 |
Why?
|
Brain Mapping | 4 | 2024 | 644 | 0.580 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2017 | 96 | 0.570 |
Why?
|
Deep Brain Stimulation | 3 | 2019 | 348 | 0.570 |
Why?
|
Infant | 25 | 2023 | 13310 | 0.520 |
Why?
|
Bone Screws | 6 | 2011 | 84 | 0.520 |
Why?
|
Minimally Invasive Surgical Procedures | 3 | 2019 | 500 | 0.500 |
Why?
|
Anesthetics, Combined | 1 | 2014 | 14 | 0.500 |
Why?
|
Microelectrodes | 1 | 2014 | 52 | 0.500 |
Why?
|
Intraoperative Neurophysiological Monitoring | 1 | 2014 | 32 | 0.490 |
Why?
|
Neurophysiological Monitoring | 1 | 2014 | 23 | 0.490 |
Why?
|
Tumor Burden | 1 | 2020 | 1987 | 0.480 |
Why?
|
Vagus Nerve Stimulation | 3 | 2022 | 59 | 0.480 |
Why?
|
Hydrocephalus | 4 | 2011 | 217 | 0.480 |
Why?
|
Cerebrospinal Fluid Shunts | 3 | 2012 | 71 | 0.460 |
Why?
|
Neuroendoscopy | 4 | 2011 | 31 | 0.450 |
Why?
|
Dystonic Disorders | 1 | 2014 | 81 | 0.450 |
Why?
|
Adolescent | 32 | 2023 | 31252 | 0.450 |
Why?
|
Neural Tube Defects | 3 | 2019 | 341 | 0.440 |
Why?
|
Hyperthermia, Induced | 1 | 2017 | 510 | 0.440 |
Why?
|
Kyphosis | 5 | 2012 | 43 | 0.400 |
Why?
|
Surface-Active Agents | 3 | 2007 | 41 | 0.390 |
Why?
|
Anesthesia | 1 | 2014 | 296 | 0.380 |
Why?
|
Treatment Outcome | 24 | 2023 | 32848 | 0.370 |
Why?
|
Humans | 80 | 2024 | 261506 | 0.360 |
Why?
|
Cervical Vertebrae | 5 | 2012 | 205 | 0.350 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2023 | 624 | 0.340 |
Why?
|
Male | 49 | 2023 | 123000 | 0.340 |
Why?
|
Quinolinic Acid | 2 | 2004 | 23 | 0.320 |
Why?
|
Spine | 5 | 2012 | 293 | 0.310 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2020 | 1648 | 0.300 |
Why?
|
Young Adult | 13 | 2023 | 21445 | 0.290 |
Why?
|
Neurosurgery | 2 | 2022 | 108 | 0.290 |
Why?
|
Female | 48 | 2023 | 141928 | 0.290 |
Why?
|
Lumbar Vertebrae | 3 | 2011 | 245 | 0.270 |
Why?
|
Dandy-Walker Syndrome | 1 | 2005 | 11 | 0.270 |
Why?
|
Postoperative Complications | 11 | 2019 | 5542 | 0.270 |
Why?
|
Radiosurgery | 1 | 2013 | 1330 | 0.240 |
Why?
|
Retrospective Studies | 22 | 2023 | 37905 | 0.240 |
Why?
|
Thoracic Vertebrae | 5 | 2012 | 186 | 0.240 |
Why?
|
Hippocampus | 3 | 2020 | 915 | 0.240 |
Why?
|
Surgical Wound Infection | 2 | 2018 | 450 | 0.230 |
Why?
|
Injections, Spinal | 2 | 2019 | 257 | 0.230 |
Why?
|
Catheterization | 1 | 2005 | 410 | 0.220 |
Why?
|
Necrosis | 1 | 2004 | 580 | 0.220 |
Why?
|
Muscle Relaxants, Central | 2 | 2019 | 28 | 0.220 |
Why?
|
Baclofen | 2 | 2019 | 42 | 0.220 |
Why?
|
Electrodes, Implanted | 3 | 2021 | 183 | 0.220 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 142 | 0.210 |
Why?
|
Quadriplegia | 1 | 2021 | 43 | 0.200 |
Why?
|
Diffusion Tensor Imaging | 1 | 2023 | 303 | 0.200 |
Why?
|
Functional Laterality | 2 | 2020 | 316 | 0.190 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 4971 | 0.190 |
Why?
|
Spinal Neoplasms | 3 | 2011 | 631 | 0.190 |
Why?
|
Infratentorial Neoplasms | 2 | 2010 | 45 | 0.180 |
Why?
|
Dengue Vaccines | 1 | 2019 | 12 | 0.180 |
Why?
|
Intracranial Aneurysm | 2 | 2012 | 123 | 0.180 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 4892 | 0.180 |
Why?
|
Skull Fractures | 1 | 1999 | 46 | 0.180 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2010 | 40 | 0.170 |
Why?
|
Meningomyelocele | 2 | 2012 | 183 | 0.170 |
Why?
|
Follow-Up Studies | 6 | 2020 | 14889 | 0.170 |
Why?
|
Ependymoma | 1 | 2021 | 242 | 0.170 |
Why?
|
Spasms, Infantile | 1 | 2020 | 165 | 0.170 |
Why?
|
Reoperation | 4 | 2018 | 1382 | 0.170 |
Why?
|
Hematoma | 1 | 1999 | 160 | 0.160 |
Why?
|
Scoliosis | 4 | 2012 | 139 | 0.160 |
Why?
|
Single-Blind Method | 1 | 2019 | 409 | 0.160 |
Why?
|
Joint Instability | 2 | 2009 | 88 | 0.160 |
Why?
|
Infusion Pumps, Implantable | 1 | 2018 | 51 | 0.160 |
Why?
|
Electrocoagulation | 1 | 2018 | 65 | 0.160 |
Why?
|
Brain Injuries | 1 | 2004 | 787 | 0.160 |
Why?
|
Microsurgery | 2 | 2011 | 244 | 0.150 |
Why?
|
Astrocytoma | 2 | 2010 | 321 | 0.150 |
Why?
|
Cerebral Cortex | 3 | 2018 | 621 | 0.150 |
Why?
|
Craniotomy | 2 | 2017 | 304 | 0.150 |
Why?
|
Postoperative Period | 1 | 2019 | 665 | 0.150 |
Why?
|
Tissue Banks | 1 | 2016 | 55 | 0.140 |
Why?
|
Language | 1 | 2018 | 309 | 0.140 |
Why?
|
Ankyrins | 1 | 2016 | 104 | 0.140 |
Why?
|
Malformations of Cortical Development, Group I | 1 | 2015 | 4 | 0.140 |
Why?
|
Embolization, Therapeutic | 2 | 2012 | 551 | 0.140 |
Why?
|
Fornix, Brain | 1 | 2015 | 20 | 0.140 |
Why?
|
Neurons | 3 | 2010 | 2287 | 0.140 |
Why?
|
Nervous System Diseases | 2 | 2012 | 500 | 0.130 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 181 | 0.130 |
Why?
|
Laminectomy | 2 | 2019 | 52 | 0.130 |
Why?
|
Encephalitis | 1 | 2016 | 143 | 0.130 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 925 | 0.130 |
Why?
|
Nicardipine | 1 | 2014 | 14 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 10 | 2012 | 7551 | 0.130 |
Why?
|
Cohort Studies | 5 | 2020 | 9244 | 0.130 |
Why?
|
Anesthetics, Dissociative | 1 | 2014 | 22 | 0.120 |
Why?
|
Emergency Medical Services | 2 | 2010 | 429 | 0.120 |
Why?
|
Inflammation | 1 | 2004 | 2522 | 0.120 |
Why?
|
Prospective Studies | 3 | 2019 | 12873 | 0.120 |
Why?
|
Radiography | 7 | 2012 | 1904 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 306 | 0.120 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 460 | 0.110 |
Why?
|
Neuroprotective Agents | 2 | 2007 | 215 | 0.110 |
Why?
|
Wakefulness | 1 | 2014 | 150 | 0.110 |
Why?
|
Dexmedetomidine | 1 | 2014 | 85 | 0.110 |
Why?
|
Oxygen | 1 | 2017 | 754 | 0.110 |
Why?
|
Bipolar Disorder | 1 | 2016 | 376 | 0.110 |
Why?
|
Internal Fixators | 1 | 2012 | 14 | 0.110 |
Why?
|
Arthrodesis | 1 | 2012 | 12 | 0.110 |
Why?
|
Perioperative Care | 1 | 2017 | 451 | 0.110 |
Why?
|
Rett Syndrome | 1 | 2015 | 262 | 0.110 |
Why?
|
Monitoring, Intraoperative | 2 | 2011 | 264 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 218 | 0.110 |
Why?
|
Pyrazoles | 1 | 2021 | 1471 | 0.110 |
Why?
|
Tuberculosis, Spinal | 1 | 2012 | 12 | 0.110 |
Why?
|
Aneurysm, Ruptured | 1 | 2012 | 45 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2022 | 6009 | 0.110 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2011 | 209 | 0.110 |
Why?
|
Cranial Sutures | 1 | 2012 | 31 | 0.100 |
Why?
|
Sympathectomy | 1 | 2011 | 14 | 0.100 |
Why?
|
Memory | 1 | 2015 | 429 | 0.100 |
Why?
|
Posters as Topic | 1 | 2011 | 8 | 0.100 |
Why?
|
Osteoblastoma | 1 | 2011 | 15 | 0.100 |
Why?
|
Amenorrhea | 1 | 2011 | 34 | 0.100 |
Why?
|
Cauda Equina | 1 | 2011 | 12 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 3 | 2007 | 2063 | 0.100 |
Why?
|
Diskectomy | 1 | 2011 | 10 | 0.100 |
Why?
|
Ventriculostomy | 1 | 2011 | 34 | 0.100 |
Why?
|
Intervertebral Disc Displacement | 1 | 2011 | 28 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2012 | 121 | 0.100 |
Why?
|
Internship and Residency | 1 | 2022 | 1375 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 395 | 0.100 |
Why?
|
Publications | 1 | 2011 | 54 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2012 | 138 | 0.100 |
Why?
|
Sleep | 1 | 2014 | 413 | 0.100 |
Why?
|
Fracture Fixation | 1 | 2011 | 35 | 0.100 |
Why?
|
Hypertensive Encephalopathy | 1 | 2010 | 5 | 0.100 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 58 | 0.100 |
Why?
|
Thoracoscopy | 1 | 2011 | 101 | 0.100 |
Why?
|
Peer Review, Research | 1 | 2011 | 66 | 0.100 |
Why?
|
Vein of Galen Malformations | 1 | 2010 | 5 | 0.100 |
Why?
|
Long QT Syndrome | 1 | 2011 | 92 | 0.090 |
Why?
|
Craniosynostoses | 1 | 2012 | 98 | 0.090 |
Why?
|
Subarachnoid Space | 1 | 2010 | 36 | 0.090 |
Why?
|
Malformations of Cortical Development | 1 | 2010 | 57 | 0.090 |
Why?
|
Ketamine | 1 | 2014 | 234 | 0.090 |
Why?
|
Polyesters | 1 | 2010 | 53 | 0.090 |
Why?
|
Respiratory Tract Fistula | 1 | 2010 | 33 | 0.090 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2010 | 49 | 0.090 |
Why?
|
Neuralgia | 1 | 2013 | 251 | 0.090 |
Why?
|
Pleural Diseases | 1 | 2010 | 57 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2021 | 4849 | 0.090 |
Why?
|
Critical Pathways | 1 | 2010 | 149 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2011 | 298 | 0.090 |
Why?
|
Neuroendoscopes | 1 | 2009 | 3 | 0.090 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2009 | 16 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 2010 | 206 | 0.090 |
Why?
|
Choroid Plexus | 1 | 2009 | 31 | 0.090 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 268 | 0.090 |
Why?
|
Cervical Atlas | 1 | 2009 | 19 | 0.090 |
Why?
|
Atlanto-Axial Joint | 1 | 2009 | 25 | 0.080 |
Why?
|
Chondroma | 1 | 2009 | 31 | 0.080 |
Why?
|
Hydrothorax | 1 | 2008 | 18 | 0.080 |
Why?
|
Ophthalmoplegia | 1 | 2009 | 79 | 0.080 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2009 | 41 | 0.080 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 70 | 0.080 |
Why?
|
Cisterna Magna | 2 | 2007 | 6 | 0.080 |
Why?
|
Piperidines | 1 | 2014 | 1035 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3518 | 0.080 |
Why?
|
Periosteum | 1 | 2009 | 39 | 0.080 |
Why?
|
Thoracotomy | 1 | 2010 | 220 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 1546 | 0.080 |
Why?
|
Rhabdoid Tumor | 1 | 2009 | 110 | 0.080 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2012 | 95 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2010 | 301 | 0.080 |
Why?
|
Corpus Striatum | 2 | 2007 | 104 | 0.080 |
Why?
|
Geography | 1 | 2008 | 140 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 2992 | 0.080 |
Why?
|
Spinal Cord | 3 | 2023 | 690 | 0.080 |
Why?
|
Rats | 3 | 2007 | 6086 | 0.080 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2011 | 393 | 0.080 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2007 | 3 | 0.080 |
Why?
|
Pneumothorax | 1 | 2008 | 153 | 0.080 |
Why?
|
Patient Transfer | 1 | 2008 | 137 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1360 | 0.070 |
Why?
|
Hospitalization | 1 | 2014 | 2083 | 0.070 |
Why?
|
Databases, Factual | 3 | 2019 | 2218 | 0.070 |
Why?
|
Neuronavigation | 1 | 2005 | 47 | 0.070 |
Why?
|
Cerebellar Neoplasms | 1 | 2010 | 434 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2010 | 2927 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2010 | 1130 | 0.060 |
Why?
|
Medulloblastoma | 1 | 2010 | 540 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2008 | 672 | 0.060 |
Why?
|
Vasospasm, Intracranial | 1 | 2004 | 22 | 0.060 |
Why?
|
Magnesium Sulfate | 1 | 2004 | 39 | 0.060 |
Why?
|
Length of Stay | 3 | 2019 | 1900 | 0.060 |
Why?
|
Heart-Assist Devices | 1 | 2012 | 1171 | 0.060 |
Why?
|
Vagus Nerve | 1 | 2022 | 63 | 0.050 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2022 | 84 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2011 | 1237 | 0.050 |
Why?
|
Benchmarking | 1 | 2024 | 273 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2007 | 1129 | 0.050 |
Why?
|
Receptor, trkB | 1 | 2021 | 53 | 0.050 |
Why?
|
Adult | 7 | 2023 | 77950 | 0.050 |
Why?
|
Workload | 1 | 2022 | 198 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2023 | 341 | 0.050 |
Why?
|
Electrodes | 1 | 2020 | 116 | 0.050 |
Why?
|
Age Factors | 4 | 2011 | 5377 | 0.050 |
Why?
|
Animals | 7 | 2016 | 59536 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 275 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 129 | 0.040 |
Why?
|
Artifacts | 1 | 2022 | 532 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 1999 | 215 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2015 | 7222 | 0.040 |
Why?
|
Vaccines, Attenuated | 1 | 2019 | 210 | 0.040 |
Why?
|
Goals | 1 | 2020 | 185 | 0.040 |
Why?
|
Hospitals | 1 | 2022 | 485 | 0.040 |
Why?
|
Immunization Programs | 1 | 2019 | 73 | 0.040 |
Why?
|
Operative Time | 1 | 2019 | 217 | 0.040 |
Why?
|
Dengue Virus | 1 | 2019 | 123 | 0.040 |
Why?
|
Dengue | 1 | 2019 | 109 | 0.040 |
Why?
|
World Health Organization | 1 | 2019 | 316 | 0.040 |
Why?
|
Periodicity | 1 | 2018 | 68 | 0.040 |
Why?
|
Macrophages | 1 | 2004 | 1304 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2018 | 129 | 0.040 |
Why?
|
Equipment Failure | 1 | 2018 | 191 | 0.040 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 309 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 305 | 0.040 |
Why?
|
Parvalbumins | 1 | 2016 | 30 | 0.040 |
Why?
|
Checklist | 1 | 2018 | 122 | 0.040 |
Why?
|
Public Health | 1 | 2019 | 299 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 1073 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 671 | 0.040 |
Why?
|
Obesity | 1 | 2009 | 2884 | 0.030 |
Why?
|
Spatial Learning | 1 | 2015 | 16 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2015 | 46 | 0.030 |
Why?
|
Device Removal | 1 | 2018 | 337 | 0.030 |
Why?
|
Interneurons | 1 | 2016 | 144 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 467 | 0.030 |
Why?
|
Middle Aged | 5 | 2018 | 86204 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2016 | 842 | 0.030 |
Why?
|
Specimen Handling | 1 | 2016 | 299 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2015 | 176 | 0.030 |
Why?
|
Fear | 1 | 2015 | 254 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2019 | 610 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 1178 | 0.030 |
Why?
|
Software | 1 | 2021 | 1321 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2016 | 584 | 0.030 |
Why?
|
Neurogenesis | 1 | 2015 | 238 | 0.030 |
Why?
|
Exons | 1 | 2016 | 1328 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2019 | 1320 | 0.030 |
Why?
|
Spondylitis | 1 | 2012 | 7 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2005 | 8223 | 0.030 |
Why?
|
Head Protective Devices | 1 | 2012 | 26 | 0.030 |
Why?
|
Recurrence | 1 | 2020 | 4758 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 1085 | 0.030 |
Why?
|
Stellate Ganglion | 1 | 2011 | 15 | 0.030 |
Why?
|
Back Pain | 1 | 2012 | 61 | 0.030 |
Why?
|
Ganglia, Sympathetic | 1 | 2011 | 32 | 0.030 |
Why?
|
Atenolol | 1 | 2011 | 42 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2015 | 1764 | 0.030 |
Why?
|
Time Factors | 2 | 2010 | 12926 | 0.030 |
Why?
|
Adjuvants, Anesthesia | 1 | 2011 | 8 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 216 | 0.030 |
Why?
|
Syncope | 1 | 2011 | 64 | 0.030 |
Why?
|
Third Ventricle | 1 | 2011 | 37 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 848 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 2315 | 0.020 |
Why?
|
Pyramidal Tracts | 1 | 2011 | 57 | 0.020 |
Why?
|
Gait | 1 | 2012 | 165 | 0.020 |
Why?
|
Quality Improvement | 1 | 2018 | 851 | 0.020 |
Why?
|
Patient Positioning | 1 | 2012 | 195 | 0.020 |
Why?
|
Organizational Policy | 1 | 2010 | 73 | 0.020 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2010 | 26 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2010 | 142 | 0.020 |
Why?
|
Ganglioneuroma | 1 | 2010 | 41 | 0.020 |
Why?
|
Apoptosis | 1 | 2004 | 7591 | 0.020 |
Why?
|
Skull | 1 | 2012 | 231 | 0.020 |
Why?
|
Fentanyl | 1 | 2011 | 148 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2011 | 426 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2015 | 786 | 0.020 |
Why?
|
Linear Models | 1 | 2012 | 1085 | 0.020 |
Why?
|
Cognition | 1 | 2015 | 968 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 323 | 0.020 |
Why?
|
Anesthesia, General | 1 | 2011 | 239 | 0.020 |
Why?
|
Safety | 1 | 2011 | 465 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 1183 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 5159 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2010 | 192 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2016 | 4143 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2011 | 221 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2009 | 141 | 0.020 |
Why?
|
Midwestern United States | 1 | 2008 | 18 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 2265 | 0.020 |
Why?
|
Pleural Effusion | 1 | 2010 | 201 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2010 | 829 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2010 | 295 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 269 | 0.020 |
Why?
|
Postoperative Care | 1 | 2012 | 739 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 1823 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2010 | 252 | 0.020 |
Why?
|
Phosphorylation | 1 | 2015 | 4804 | 0.020 |
Why?
|
Synaptic Membranes | 1 | 2007 | 16 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 650 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2007 | 114 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2007 | 4938 | 0.020 |
Why?
|
Recovery of Function | 1 | 2010 | 703 | 0.020 |
Why?
|
Thoracic Neoplasms | 1 | 2010 | 337 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2007 | 157 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 462 | 0.020 |
Why?
|
Quality of Life | 1 | 2020 | 4532 | 0.020 |
Why?
|
Surgery, Plastic | 1 | 2012 | 344 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 585 | 0.020 |
Why?
|
Sex Factors | 1 | 2011 | 2139 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2010 | 773 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2011 | 2292 | 0.020 |
Why?
|
Equipment Design | 1 | 2009 | 1204 | 0.020 |
Why?
|
Acute Disease | 1 | 2010 | 2422 | 0.020 |
Why?
|
Societies, Medical | 1 | 2011 | 1335 | 0.020 |
Why?
|
Mice | 2 | 2016 | 34495 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 4549 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2015 | 7548 | 0.020 |
Why?
|
Logistic Models | 1 | 2011 | 3441 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2004 | 137 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 4298 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 5539 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 10035 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 17523 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 2352 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 3443 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 3472 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 2594 | 0.010 |
Why?
|
Cell Survival | 1 | 2007 | 3045 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 3890 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8865 | 0.010 |
Why?
|
United States | 1 | 2014 | 15433 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 9180 | 0.010 |
Why?
|
Risk Assessment | 1 | 2009 | 6869 | 0.010 |
Why?
|
Survival Rate | 1 | 2009 | 12221 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 21713 | 0.010 |
Why?
|